The implementation of Tosca served as the foundation for the company’s managed testing services model. With a centralized governance structure and a 40-person peak team size, the TCoE began delivering verification and validation testing services across the organization. This standardized process ensured that quality was consistently high, regardless of the project or department, led by thorough and collaborative implementation from Cognizant.
A key benefit was the improvement in reporting and metrics. By integrating Tosca with Jira and Zephyr, the TCoE gained the ability to provide accurate, real-time reporting. This visibility allowed for better tracking of a strong metrics baseline and continuous improvement planning. The results were clear: with nearly 8,900 test cases executed, the team identified approximately 1,090 defects, achieving a remarkable 0% defect leakage into production. This level of quality is critical in a regulated industry and solidified the TCoE’s value to the business.
The financial impact was also substantial. The efficiency gains from Tricentis automation and Cognizant oversight led to over $600,000 in savings, freeing up resources to focus on innovation and strategy.
“Cognizant partnered with a leading U.S. biotechnology company to modernize quality engineering through a Tosca powered Managed Testing Services model. The transformation delivered 80% automation coverage, eliminated production defects, and generated $600K in savings, accelerating releases without compromising compliance,” attests Nirmalkumar Ramachandran, SBU Head, Healthcare & Lifesciences & QE&A at Cognizant.